Research Article
The Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance
Table 2
Reasons for nonresection.
| Final diagnosis | Number (%) | Peritoneal disease | Disease progression | No/benign disease |
| Colorectal metastases (CRM) | 7/270 | (2.6) | 4 | 3 | 0 | Hepatoma | 2/33 | (6) | 0 | 2 | 0 | Hilar cholangiocarcinoma | 4/23 | (17) | 0 | 4 | 0 | Gall bladder carcinoma (GBC) | 2/19 | (11) | 2 | 0 | 0 | Other metastases | 3/30 | (10) | 1 | 2 | 0 | Neuroendocrine tumour (NET) | 1/13 | (8) | 0 | 1 | 0 | Haemangioma | 1/9 | (11) | 0 | 0 | 1 | Normal liver | 1 | ā | 0 | 0 | 1 |
| Total | 21 | (4.8) | 7 | 12 | 2 |
|
|